Your browser doesn't support javascript.
loading
Characteristics of white blood cell count in acute lymphoblastic leukemia: A COST LEGEND phenotype-genotype study.
Helenius, Marianne; Vaitkeviciene, Goda; Abrahamsson, Jonas; Jonsson, Ólafur Gisli; Lund, Bendik; Harila-Saari, Arja; Vettenranta, Kim; Mikkel, Sirje; Stanulla, Martin; Lopez-Lopez, Elixabet; Waanders, Esmé; Madsen, Hans O; Marquart, Hanne Vibeke; Modvig, Signe; Gupta, Ramneek; Schmiegelow, Kjeld; Nielsen, Rikke Linnemann.
Afiliación
  • Helenius M; Department of Health Technology, Technical University of Denmark, Kongens Lyngby, Copenhagen, Denmark.
  • Vaitkeviciene G; Department of Pediatrics and Adolescent Medicine, University Hospital Rigshospitalet, Copenhagen, Denmark.
  • Abrahamsson J; Vilnius University Hospital Santaros Klinikos Center for Pediatric Oncology and Hematology and Vilnius University, Vilnius, Lithuania.
  • Jonsson ÓG; Department of Paediatrics, Institution for Clinical Sciences, Sahlgrenska University Hospital, Gothenburg, Sweden.
  • Lund B; Department of Pediatrics, Landspitali University Hospital, Reykjavík, Iceland.
  • Harila-Saari A; Department of Pediatrics, St. Olavs Hospital, Trondheim, Norway.
  • Vettenranta K; Department of Women's and Children's Health, Uppsala University, Uppsala, Sweden.
  • Mikkel S; University of Helsinki and Children´s Hospital, University of Helsinki, Helsinki, Finland.
  • Stanulla M; Department of Hematology and Oncology, University of Tartu, Tartu, Estonia.
  • Lopez-Lopez E; Department of Pediatric Hematology and Oncology, Hannover Medical School, Hannover, Germany.
  • Waanders E; Department of Genetics, Physical Anthropology and Animal Physiology, Faculty of Science and Technology, University of the Basque Country (UPV/EHU), Leioa, Spain.
  • Madsen HO; Pediatric Oncology Group, BioCruces Bizkaia Health Research Institute, Barakaldo, Spain.
  • Marquart HV; Department of Genetics, University Medical Center Utrecht, Utrecht, The Netherlands.
  • Modvig S; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.
  • Gupta R; Department of Clinical Immunology, University Hospital Rigshospitalet, Copenhagen, Denmark.
  • Schmiegelow K; Department of Clinical Immunology, University Hospital Rigshospitalet, Copenhagen, Denmark.
  • Nielsen RL; Department of Clinical Immunology, University Hospital Rigshospitalet, Copenhagen, Denmark.
Pediatr Blood Cancer ; 69(6): e29582, 2022 06.
Article en En | MEDLINE | ID: mdl-35316565

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Leucemia-Linfoma Linfoblástico de Células Precursoras / Leucemia-Linfoma Linfoblástico de Células T Precursoras Tipo de estudio: Guideline / Health_economic_evaluation / Prognostic_studies Límite: Humans Idioma: En Revista: Pediatr Blood Cancer Asunto de la revista: HEMATOLOGIA / NEOPLASIAS / PEDIATRIA Año: 2022 Tipo del documento: Article País de afiliación: Dinamarca

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Leucemia-Linfoma Linfoblástico de Células Precursoras / Leucemia-Linfoma Linfoblástico de Células T Precursoras Tipo de estudio: Guideline / Health_economic_evaluation / Prognostic_studies Límite: Humans Idioma: En Revista: Pediatr Blood Cancer Asunto de la revista: HEMATOLOGIA / NEOPLASIAS / PEDIATRIA Año: 2022 Tipo del documento: Article País de afiliación: Dinamarca